ENDRA Life Sciences (NDRA) Return on Equity (2017 - 2026)

ENDRA Life Sciences (NDRA) has 10 years of Return on Equity data on file, last reported at 0.04% in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.04%, up 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.04% (up 1.0% YoY), and the FY2025 annual result was 0.03%, changed 0.0% from the prior year.
• Return on Equity rose to 0.04% in Q1 2026 per NDRA's latest filing, from 0.06% in the prior quarter.
• Over five years, Return on Equity peaked at 0.01% in Q2 2022 and troughed at 0.1% in Q3 2025.
• A 5-year average of 0.03% and a median of 0.02% in 2024 frame the typical range for Return on Equity.
• The sharpest annual moves came in 2024 and 2025: Return on Equity rose 1 bps in 2024, then dropped 9 bps in 2025.
• A 5-year view of Return on Equity shows it stood at 0.02% in 2022, then decreased by 22 bps to 0.02% in 2023, then slumped by 35 bps to 0.03% in 2024, then slumped by 130 bps to 0.06% in 2025, then jumped by 38 bps to 0.04% in 2026.
• Business Quant data shows NDRA's Return on Equity at 0.04% in Q1 2026, 0.06% in Q4 2025, and 0.1% in Q3 2025.